Compared to standard imaging methods such as bone scans, CT, and MRI, PSMA-targeted imaging, like PSMA PET/CT, offers superior sensitivity and specificity in identifying prostate cancer, especially in the initial staging of prostate cancer (Figure 1 and Figure 2). The gene discussed is FOLH1; the disease is prostate carcinoma.